rs34929837

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000379.4(XDH):​c.1184A>T​(p.Lys395Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00404 in 1,614,144 control chromosomes in the GnomAD database, including 206 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 93 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 113 hom. )

Consequence

XDH
NM_000379.4 missense

Scores

2
7
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.789

Publications

8 publications found
Variant links:
Genes affected
XDH (HGNC:12805): (xanthine dehydrogenase) Xanthine dehydrogenase belongs to the group of molybdenum-containing hydroxylases involved in the oxidative metabolism of purines. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Xanthine dehydrogenase can be converted to xanthine oxidase by reversible sulfhydryl oxidation or by irreversible proteolytic modification. Defects in xanthine dehydrogenase cause xanthinuria, may contribute to adult respiratory stress syndrome, and may potentiate influenza infection through an oxygen metabolite-dependent mechanism. [provided by RefSeq, Jan 2014]
XDH Gene-Disease associations (from GenCC):
  • xanthinuria type I
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006719202).
BP6
Variant 2-31379925-T-A is Benign according to our data. Variant chr2-31379925-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 335791.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0665 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XDHNM_000379.4 linkc.1184A>T p.Lys395Met missense_variant Exon 13 of 36 ENST00000379416.4 NP_000370.2
XDHXM_011533095.3 linkc.1184A>T p.Lys395Met missense_variant Exon 13 of 36 XP_011531397.1
XDHXM_011533096.3 linkc.1184A>T p.Lys395Met missense_variant Exon 13 of 29 XP_011531398.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XDHENST00000379416.4 linkc.1184A>T p.Lys395Met missense_variant Exon 13 of 36 1 NM_000379.4 ENSP00000368727.3

Frequencies

GnomAD3 genomes
AF:
0.0200
AC:
3040
AN:
152190
Hom.:
93
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0687
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00792
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.0125
GnomAD2 exomes
AF:
0.00544
AC:
1367
AN:
251474
AF XY:
0.00383
show subpopulations
Gnomad AFR exome
AF:
0.0704
Gnomad AMR exome
AF:
0.00309
Gnomad ASJ exome
AF:
0.00546
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000387
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00238
AC:
3480
AN:
1461836
Hom.:
113
Cov.:
31
AF XY:
0.00205
AC XY:
1491
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.0750
AC:
2512
AN:
33478
American (AMR)
AF:
0.00342
AC:
153
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00524
AC:
137
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000151
AC:
13
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00348
AC:
20
AN:
5740
European-Non Finnish (NFE)
AF:
0.000269
AC:
299
AN:
1111998
Other (OTH)
AF:
0.00573
AC:
346
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
193
387
580
774
967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0200
AC:
3043
AN:
152308
Hom.:
93
Cov.:
32
AF XY:
0.0192
AC XY:
1428
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0686
AC:
2852
AN:
41566
American (AMR)
AF:
0.00797
AC:
122
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000382
AC:
26
AN:
68024
Other (OTH)
AF:
0.0123
AC:
26
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
144
288
432
576
720
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00372
Hom.:
23
Bravo
AF:
0.0237
ESP6500AA
AF:
0.0660
AC:
291
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00648
AC:
787
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000818
EpiControl
AF:
0.000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 06, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary xanthinuria type 1 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Xanthinuria type II Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.16
T
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.97
D
MetaRNN
Benign
0.0067
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
3.4
M
PhyloP100
0.79
PrimateAI
Benign
0.35
T
PROVEAN
Uncertain
-4.0
D
REVEL
Benign
0.21
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.0090
D
Polyphen
0.97
D
Vest4
0.52
MVP
0.55
MPC
0.24
ClinPred
0.045
T
GERP RS
0.73
Varity_R
0.53
gMVP
0.76
Mutation Taster
=85/15
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34929837; hg19: chr2-31602791; API